Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Leukemia 4Breast Neoplasms 4Philadelphia Chromosome 3Neoplasms 3Neoplasm Metastasis 2Leukemia, Myeloid 2Bronchiolitis Obliterans Syndrome 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Translocation, Genetic 1Thymus Neoplasms 1Thymoma 1Pathologic Processes 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1Mesothelioma 1Leukemia, Myeloid, Chronic-Phase 1Hematologic Diseases 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Diseases 1Blast Crisis 1

Interventions

Temozolomide 203Radiotherapy 118Bevacizumab 93Radiation 40Magnetic Resonance Spectroscopy 28Irinotecan 27Carmustine 25Surgical Procedures, Operative 24Lomustine 21Erlotinib Hydrochloride 19Chemotherapy, Adjuvant 18Carboplatin 17temsirolimus 13Drug Therapy 13O(6)-benzylguanine 12Nivolumab 12sargramostim 11Sirolimus 11Radiotherapy, Intensity-Modulated 11Radiotherapy, Conformal 11Sorafenib 10Radiosurgery 10Imatinib Mesylate 10Everolimus 10pembrolizumab 9motexafin gadolinium 9Vorinostat 9Thalidomide 8IL13-PE38 8Gefitinib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Glioblastoma × bosutinib × Clear all
NCT01331291 2016-07-25

Bosutinib in Adult Patients With Recurrent Glioblastoma

Massachusetts General Hospital

Phase 2 Completed
36 enrolled 9 charts
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡